New comparisons among ALK-targeted therapies could sharpen treatment decisions in lung cancer
New comparisons among ALK-targeted therapies could sharpen treatment decisions in lung cancer In ALK-positive lung cancer, the rise of targeted therapy has changed more than prognosis. It has also changed the kind of decisions oncologists have to mak...
Read more







